Also trades as: NAVB (OTC) · $vol 0M
NAVBQ Earnings
Navidea Biopharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +9900.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±20590.2%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Next Earnings
2026-11-16
EPS Estimate
$-0.09
Range: $-0.09 - $-0.09
Revenue Estimate
$600K
1 analysts
Estimate vs Actual
Earnings Surprise History
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | quarter | 2027-06-30 | $— | $-0.03 | ▼ 0.03 | $— | $1,800,000 |
| 2026-09-30 | quarter | 2027-03-30 | $-0.03 | $-0.09 | ▼ 0.06 | $1,800,000 | $600,000 |
| 2026-09-30 | quarter | 2026-09-30 | $-0.09 | $-0.08 | ▲ 0.01 | $600,000 | $600,000 |
| 2026-07-06 | quarter | 2027-03-30 | $— | $-0.03 | ▼ 0.03 | $— | $1,800,000 |
| 2026-07-06 | quarter | 2026-12-30 | $-0.03 | $-0.09 | ▼ 0.06 | $1,800,000 | $600,000 |
| 2026-07-06 | quarter | 2026-06-30 | $-0.09 | $-0.08 | ▲ 0.01 | $600,000 | $600,000 |
| 2026-03-31 | quarter | 2026-09-30 | $-0.03 | $-0.09 | ▼ 0.06 | $1,800,000 | $600,000 |
| 2026-03-31 | quarter | 2026-03-30 | $-0.09 | $-0.08 | ▲ 0.01 | $600,000 | $600,000 |
| 2026-03-31 | quarter | 2026-12-30 | $— | $-0.03 | ▼ 0.03 | $— | $1,800,000 |
| 2026-01-23 | annual | 2025-12-31 | $— | $2.36 | ▲ 2.36 | $— | $112,467,000 |
| 2026-01-23 | annual | 2024-12-31 | $— | $0.57 | ▲ 0.57 | $— | $44,545,000 |
| 2026-01-23 | quarter | 2026-09-30 | $— | $-0.03 | ▼ 0.03 | $— | $1,800,000 |
| 2026-01-23 | quarter | 2026-06-30 | $— | $-0.09 | ▼ 0.09 | $— | $600,000 |
| 2026-01-23 | quarter | 2026-03-30 | $— | $-0.09 | ▼ 0.09 | $— | $600,000 |
| 2026-01-23 | quarter | 2025-12-30 | $— | $-0.08 | ▼ 0.08 | $— | $600,000 |
Earnings Call Transcripts
No transcripts available.